Abstract |
Asthenia (or fatigue) is one of the most common symptoms in palliative patients. Methylphenidate is currently being assessed for treating this condition. A review of related literature published to date was performed, revealing methylphenidate to be a safe drug which could decrease fatigue in palliative patients with a tolerable side-effects profile.
|
Authors | A Saralegui, P Palacio, P Royo |
Journal | Anales del sistema sanitario de Navarra
(An Sist Sanit Navar)
Vol. 36
Issue 2
Pg. 287-93
(Sep 06 2013)
ISSN: 2340-3527 [Electronic] Spain |
Vernacular Title | Revisión sobre el uso del metilfenidato para el tratamiento de la astenia en pacientes paliativos. |
PMID | 24008532
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
- Dopamine Uptake Inhibitors
- Methylphenidate
|
Topics |
- Asthenia
(drug therapy)
- Dopamine Uptake Inhibitors
(therapeutic use)
- Fatigue
(drug therapy)
- Humans
- Methylphenidate
(therapeutic use)
- Palliative Care
|